Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
108 Cards in this Set
- Front
- Back
Cushing syndrome endogenous etiology
|
abnormal adrenal gland (abnormal cortical tissues)
pituitary adenomas ectopic tumors corticotropin hypersecretion |
|
Cushing syndrome metabolic presentation
|
fat redistribution --> buffalo hump, moon face
increase in blood glucose |
|
Cushing syndrome cardiovascular presentation
|
increase in Na+/H2O retention --> increase in BP --> increased risk for HF
increase in thrombotic events |
|
Cushing syndrome integument changes
|
hirsutism
hyperpigmentation decreased wound healing increased risk of infection thinned skin --> striae |
|
Cushing syndrome muskuloskeletal presentation
|
osteoporosis
muscle wasting and weakness |
|
Cushing syndrome reproductive presentation
|
acne, hair thinning on scalp, hirsutism elsewhere, decreased libido
impotence |
|
Cushing syndrome mental presentation
|
steroid psychosis
|
|
Cushing syndrome ocular presentation
|
reversible (to a point) increased intraocular pressure
cataracts |
|
Cushing syndrome 1st-line treatment
|
surgery
|
|
Cushing syndrome pharmacologic treatment (general drug classes)
|
steroidogenic inhibitors
adrenolytic agents neuromodulators of ACTH release glucocorticoid-receptor blockers these are rarely used |
|
Addison's disease
|
chronic adrenal insufficiency
etiology: autoimmune, infection, or tumor treatment: steroid replacement therapy |
|
Adrenal crisis
|
Acute adrenal insufficiency
--> medical emergency |
|
Adrenal crisis cardiovascular presentation
|
decreased Na+/H2O --> decreased BP --> increased risk of shock
|
|
Adrenal crisis gastrointestinal presentation
|
N/V
abdominal pain (e.g. cramping) |
|
Adrenal crisis metabolic presentation
|
decreased blood glucose
decreased K+ fever |
|
Adrenal crisis integument changes
|
vitiligo
|
|
Adrenal crisis treatment
|
hydrocortisone 100mg IV q8h --> then convert to oral prednisone as tolerated
supportive therapy: fluids, K+, glucose |
|
Endogenous cortisol secretion, T1/2
|
8-15mg/day
T1/2 = 30 - 90 min T1/2-biological = 8-12 hours |
|
Homeostatic steroid action: carbohydrate metabolism
|
stimulates gluconeogenesis
decreases peripheral utilization of glucose stimulates glycogen storage |
|
Homeostatic steroid action: lipid metabolism
|
stimulates lypolysis
changes fat distribution |
|
Homeostatic steroid action: electrolyte and water balance
|
increase absorption of Na+ and water
increase excretion of K+, H+, and Ca++ decrease GI absorption of Ca++ |
|
Homeostatic steroid action: bone and growth
|
inhibits osteoblast formation
decreases cartilagenous matric and epiphyseal proliferation stimulates closing of epiphyseal plate decreases GI absorption of Ca++ (via vit D inhibition) decreases growth hormone release |
|
Homeostatic steroid action: CNS
|
may interrupt circadian rhythm
|
|
Homeostatic steroid action: immune system
|
increases neutrophils
decreases lymphocytes, monocytes, eosinophils, basophils inhibits macrophage phagocytosis |
|
corticosteroid with PK/PD profile most similar to cortisone
|
hydrocortisone
|
|
corticosteroid with PK/PD profile most similar to prednisone
|
prednisolone
|
|
corticosteroid with PK/PD profile most similar to triamcinolone
|
methylprednisolone
|
|
corticosteroid with PK/PD profile most similar to betamethasone
|
dexamethasone
|
|
four corticosteroid drugs with 0 relative mineralocorticoid potency
|
triamcinolone
methylprednisolone dexamethasone betamethasone |
|
morning cortisol level required for everyday activities
|
>15μg/dL
|
|
When, why, and how to perform ACTH test
|
when: morning cortisol is <15μg/dL
why: to see if HPA can be stimulated how: cosyntropin 250μg IV/IM |
|
general corticosteroid tapering rules
|
1. for doses > 5mg-7.5mg / day prednisone, half dose every ~week
2. when at 5mg-7.5mg / day, decrease by 1mg prednisone per week 3. monitor underlying disease for flare-ups 4. ACTH stress test for conservative tapering |
|
Range: Thyroid-stimulating hormone (TSH)
|
Normal: 0.4-6 µU/mL
|
|
Range: Thyroxin (T4) total
|
Normal: 5.0-11.0 µg/dL
|
|
Range: Triodothyronine (T3)
|
Normal: 95-190 ng/dL
|
|
3 types of hormones
|
1. Proteins/Polypeptides
2. Steroids 3. Tyrosine derivatives |
|
What dictates half-life of hormones?
|
Structure
Thyroid > Steroids/Proteins > Polypeptides > Amines |
|
Largest class of hormones
|
Polypeptides/Proteins
|
|
Supraoptic nuclei in neurohypophysis makes
|
Vasopressin (ADH)
|
|
Magnocellular cells of Paraventricular nuclei (PVN) of posterior pituitary makes
|
Oxytocin & Vassopressin (ADH)
|
|
Parvocellular cells of PVN of posterior pituitary releases
|
Anterior pituitary controlling hormones into median eminance
(CRF, TRH, GHRH, GHIH, GnRH, PIH) |
|
Composition of anterior pituitary
|
30-40% Somatotropes
20% Corticotropes 3-5% Thyrotropes, Gonadotropes, Lactotropes |
|
Somatotropes makes
|
Human growth hormone (hGH)
In response to GHRH |
|
Corticotropes make
|
Adrenocorticotropin (ACTH)
In response to CRF |
|
Thyrotropes make
|
Thyroid stimulating hormone (TSH)
In response to THR |
|
Gonadotropes make
|
Follicle stimulating hormone (FSH)
& Leutenizing hormone (LH) In response to GnRH |
|
Lactotropes make
|
Prolactin (PRL)
Dopamine (PIH) inhibits release |
|
Acromegaly caused by
|
Over secretion of growth hormone (GH)
Basically gigantism |
|
Symptom of Inappropriate ADH release (SIADH)
|
Over secretion of ADH from post. pituitary
Causes hyponatremia, fluid overload |
|
Grave's Disease
|
hyperthyroidism
s/s: sweating, eye bulging, anxiety |
|
Dwarfism
|
Undersecretion/production Growth hormone (GH)
|
|
Diabetes Insipidus
|
Undersecretion/production of vasopressin (ADH)
|
|
Layers of the Adrenal gland
|
1. Capsule
2. Glomerulosa 3. Fasciculata 4. Reticularis 5. Medulla |
|
Zona glomerulosa physiology
|
~15% of mass
Only region to express Aldosterone Synthase Makes Mineralocorticoids Under Ang II and K+ control |
|
Zona Fasciculata physiology
|
Makes glucocorticoids
Expresses 11β hydroxylase Controlled by ACTH |
|
Zona Reticularis physiology
|
Makes Androgens
Expresses 17α hydroxylase and a lyase |
|
P450SCC
|
Side chain cleavage enzyme
takes cholesterol ➝ pregnenolone |
|
Precursors for mineralocorticoids
|
Cholesterol ➝ Pregnenolone ➝ Progesterone ➝ Mineralocorticoids
|
|
Precursors for glucocorticoids
|
Cholesterol ➝ Pregnenolone ➝ 17OH Pregnenolone ➝ 17OH Progesterone ➝ Glucocorticoids
|
|
Precursors for Androgens/Estrogens
|
Cholesterol ➝ Pregnenolone ➝ DHEA ➝ Androstenedione ➝ Androgens/Estrogens
|
|
Corticosterone is a precursor for
|
Aldosterone in glomerulosa
Cortisol in Fasciculata |
|
Androstenedione is the precursor for
|
Androgens or Estrogens
|
|
This is the most abundant steroid in the human body
|
DHEA (dihydroepiandosterone)
Made in the reticularis |
|
17α-Hydroxylase makes
|
Progesterone ➝ 17 Hydroxy progesterone
Leads to cortisol production in smooth ER of Fasciculata |
|
11β-Hydroxylase makes
|
11β-deoxycortisol ➝ Cortisol
In mitochondria of fasciculata |
|
5α-Reductase makes
|
Testosterone ➝ Dihydrotestosterone (DHT)
in Smooth ER of Reticularis |
|
Aldosterone Synthase makes
|
Corticosterone ➝ Aldosterone
In mitochondria of Glomerulosa |
|
Lysodren
|
Mitotane
Inhibits P450SCC & 11β-Hydroxylase in mitochondria of adrenal cortex |
|
11-deoxycorticosterone
|
made from progesterone
converted to Corticosterone Has weak MR affinity |
|
Mitotane inhibits formation of
|
Pregnenolone and Corticosterone
in mitochondria of Adrenal cortex |
|
Mitotane is toxic at doses of
|
>4g/day
Only in fasciculata and reticularis (specific mitochondrial metabolism occurs here) |
|
Metopirone
|
Metyrapone
Inhibits 11β-Hydroxylase in adrenal cortex MR effects < Mitotane Used to test HPA function |
|
High dose Ketoconazole inhibits
|
CYP17 aka 17α-Hydroxylase
at even higher doses it inhibits P450SCC |
|
Periactin
|
Cyproheptadine
5-HT and H1 antagonist Inhibits CRF at hypothalamus and ACTH secretion at ant. pituitary |
|
Major component of colloid is
|
Thyroglobulin
|
|
Parafollicular cells secrete
|
Calcitonin
|
|
Cold will do what to HPT axis?
|
Directly stimulates hypothalamus to ↑ release of TRH
End result is ↑ Thyroid levels ↑ BMR and ↑ body heat |
|
How do heat, stress, anxiety, SNS outflow affect TRH?
|
These variables serve to decrease TRH release
|
|
Amount of Iodide necessary for thyroid synthesis
|
~1mg/week
|
|
Three functions of TSH
|
1. increases sodium-iodide symporter activity
2. increases TPO activity 3. increases release of T3 and T4 |
|
Pendrin
|
Iodide channel connecting the follicular cells and colloid
|
|
Thyroperoxidase (TPO)
|
Located in colloid
Converts Iodide to nacent Iodine (I-zero) Iodinates Thyroglobulin Couples DITs/MITs |
|
Thyroglobulin is made where?
|
Follicular cells
Consists of about 70-120 Tyrosine residues Exocytosed into colloid |
|
TPO requires this to function
|
Hydrogen peroxide (H2O2)
|
|
Organification
|
Iodination of Thyroglobulin by TPO
|
|
Iodinase
|
Involved to a lesser extent than TPO in iodination of tyrosine residues
|
|
How is thyroglobulin moved back to follicular cells?
|
Pinocytosis
|
|
How is thyroid hormone cleaved from thyroglobulin?
|
Lysosomal degradation leaving free T4 and T3
|
|
Deiodinase
|
Salvages Iodide from T3 and T4 synthesis from the leftover MIT, DIT and thyroglobulin
|
|
A deiodinase deficiency would lead to what?
|
Iodine deficiency
|
|
Grave's disease
|
Auto-Abs stimulation of TSH receptor
Causes goiter |
|
High levels of circulating iodine will cause
|
Decrease T3
and Increase TSH as a result |
|
Increased Deiodinase activity will result in
|
T2 formation
|
|
another name for TSH
|
Thyrotropin
|
|
Plasma T3 and T4 levels increase in pregnancy due to
|
Increase in Thyroid binding globulin (TBG)
Increases total thyroid levels (bound) |
|
Ultimate treatment for hyperthyroidism is?
|
radioactive Iodine, then surgery if that doesn't work
|
|
17α-Hydroxylase is absolutely required for synthesis of these two steroid classes
|
Cortisol and sex steroids
|
|
The majority of hormones are
|
Peptides
|
|
Epinephrine is made in only one place, where?
|
Cytosol of Adrenal Medulla
b/c it's only place the PNMT is expressed |
|
Where and what kind of receptor is the TSH receptor?
|
Located on follicular cells of thyroid gland
Gs GPCR |
|
T4 is converted to T3 primarily in?
|
The liver
|
|
Thick skin and nails is indicative of which thyroid disorder?
|
Hypothyroid
|
|
Thin skin, hair, and nails is indicative of which thyroid disorder?
|
Hyper
|
|
Goiters are typically larger in which thyroid disorder?
|
Hypo
The higher levels of TSH b/c no thyroid is inhibiting its release |
|
T4 half-life = ?
|
6-8 days
|
|
T3 half-life = ?
|
~24 hours
|
|
The thyroid hormone receptor is of what type?
|
Intracellular
Dimerized to RXR |
|
propylthiouracil
|
PTU
TPO inhibitor deiodinase inhibitor (stops T4 --> T3) |